Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6534
    +0.0011 (+0.16%)
     
  • OIL

    83.89
    +0.32 (+0.38%)
     
  • GOLD

    2,350.90
    +8.40 (+0.36%)
     
  • Bitcoin AUD

    97,893.42
    -1,061.97 (-1.07%)
     
  • CMC Crypto 200

    1,328.25
    -68.28 (-4.89%)
     
  • AUD/EUR

    0.6107
    +0.0034 (+0.56%)
     
  • AUD/NZD

    1.0992
    +0.0035 (+0.32%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,749.12
    +318.62 (+1.83%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,312.26
    +226.46 (+0.59%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Company News for Feb 2, 2023

  • Align Technology Inc.’s ALGN shares surged 4.8% after the company reported fourth-quarter 2022 adjusted earnings per share of $1.73, surpassing the Zacks Consensus Estimate of $1.52.    

  • Thermo Fisher Scientific Inc.’s TMO shares gained 3% after reporting fourth-quarter 2022 adjusted earnings per share of $5.40, outpacing the Zacks Consensus Estimate of $5.19.

  • Shares of Atkore Inc. ATKR soared 14.3% after the company posted first-quarter fiscal 2023 adjusted earnings per share of $4.61, beating the Zacks Consensus Estimate of $4.04.

  • Shares of WestRock Co. WRK plunged 12.7% after posting first-quarter fiscal 2023 adjusted earnings per share of $0.55, missing the Zacks Consensus Estimate of $0.60.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Align Technology, Inc. (ALGN) : Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report

WestRock Company (WRK) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research